Nguyen Thi Trieu, MD

Quick facts

Marketed products

• AntiCov-220 · Infectious disease
  AntiCov-220 is an antibody that targets the SARS-CoV-2 spike protein.
• SB-1121(1) · Other
• SB-1121(2) · Other

Phase 2 pipeline

• CTH Chronic Hepatitis B

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Nguyen Thi Trieu, MD portfolio CI brief
• Nguyen Thi Trieu, MD pipeline updates RSS